5-HT2 antagonists: A concept for the treatment of schizophrenia

Current Pharmaceutical Design

Volumn 3, Issue 4, 1997, Pages 367-390

  Leysen, Dirk ^a  

^a NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,3A,12B TETRAHYDRO 3 METHYL 1H DIBENZO[B,F]OXEPINO[10,11 C]PYRROLE; AMPEROZIDE; APOMORPHINE; BUSPIRONE; BUTYROPHENONE DERIVATIVE; CLOTIAPINE; CLOZAPINE; HALOPERIDOL; KETANSERIN; LOXAPINE; LYSERGIDE; MESULERGINE; NEUROLEPTIC AGENT; OCAPERIDONE; OLANZAPINE; PEROSPIRONE; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; QUETIAPINE; RECEPTOR SUBTYPE; REMOXIPRIDE; RISPERIDONE; RITANSERIN; SEROTONIN 2 RECEPTOR; SEROTONIN 2A ANTAGONIST; SERTINDOLE; SPIPERONE; UNINDEXED DRUG; ZIPRASIDONE; ZOTEPINE;

BINDING AFFINITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN STRUCTURE; PSYCHOSIS; RECEPTOR AFFINITY; REVIEW; SCHIZOPHRENIA;

EID: 0030863891     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Wooley, D.W. The Biochemical Basis of Psychosis, Wiley: New York, 1962.
2. Bleich, A.: Brown, S.; Kahn, R.; Van Praag, H.M. Schizophr. Bull., 1988, 14, 297.
3. Mellzer, H.Y.; Matsubara, S.; Lee, J.C. J. Pharmacol. Exp. Ther., 1989, 251, 238.
4. Iqbal, N.; Asnis, G.M.; Wetzler, S.; Kay, S.R.; Van Praag, M. Schizophr. Res., 1991, 5, 181.
5. Lieberman, J.A.; Koreen, A.R. Schizophr. Bull., 1993, 914, 371.
6. Schmidt, C.J.; Sorensen, S.M.; Kehne, J.H.; Carr, A.A.; Palfreyman, M.G. Life Sci., 1995, 2209.
7. Meltzer, H.Y. Psychopharmacology, 1989, 99, S18.
8. Hashimoto, T.; Kitamura, N.; Kajimoto, Y.; Shirai, Y.; Shirakawa, O.; Mita, T.; Nishino, N.; Tanaka C. Psychopharmacology, 1993, 112, S35.
9. Joyce, J.N.; Shane, A.; Lexow, N.; Winokur, A.; Casanova, M.F.; Kleinman, J.E. Neuropsychopharmacology, 1993, 8, 315.
10. Pandey, S.C.; Sharma, R.P.; Janicak, P.O.; Marks, R.C.; Davis, J.M.; Pandey, G.N. Psychiatry Res., 1993, 48, 57.
11. Williams J.; Spurlock, G.; McGuffin, P.; Mallet, J.; Nothen, M.M.; Gill, M.; Aschauer, H.; Nylander, P.-O.; Macciardi, F.; Owen, M.J. Lancet, 1996, 347, 1294.
12. Arranz, M.; Collier, D.; Sodhi, M.; Ball, D.; Roberts, G.; Price, J.; Sham, P.; Kerwin, R. Lancet, 1995, 346, 281.
13. Sodhi, M.S.; Arranz, M.J.; Ball, D.; Sham, P.; Curtis, D.; Roberts, G.W.; Price, J.; Collier, D.A.; Kerwin, R.W. Neuroreport, 1995, 7, 169.
14. Harrison, P.J.; Burnet, P.W.J. J. Psychopharmacology, 1997, 11, 18.
15. Leysen, J.E.; Niemegeers, C.J.E.; Tollenaere, J.P.; Laduron, P.M. Nature, 1978, 272, 168.
16. Ashby, C.R., Jr.; Wang, R.Y. Brain Res., 1990, 506, 346.
17. Matsubara, S.; Meltzer, H.Y. Life Sci., 1989, 45, 1397.
18. Lee, T.; Tang, S.W. Psychiatry Res., 1984, 12, 277.